Perrigo Share Holder Equity 2012-2025 | PRGO
Perrigo share holder equity from 2012 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
|
Perrigo Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024 | $4,319 |
| 2023 | $4,768 |
| 2022 | $4,842 |
| 2021 | $5,152 |
| 2020 | $5,655 |
| 2019 | $5,804 |
| 2018 | $5,668 |
| 2017 | $6,171 |
| 2016 | $5,958 |
| 2015 | $10,107 |
| 2015 | $10,700 |
| 2014 | $8,694 |
| 2013 | $2,333 |
| 2012 | $1,853 |
| 2011 | $1,531 |
|
Perrigo Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025-09-30 | $4,447 |
| 2025-06-30 | $4,472 |
| 2025-03-31 | $4,364 |
| 2024-12-31 | $4,319 |
| 2024-09-30 | $4,566 |
| 2024-06-30 | $4,545 |
| 2024-03-31 | $4,687 |
| 2023-12-31 | $4,768 |
| 2023-09-30 | $4,738 |
| 2023-06-30 | $4,849 |
| 2023-03-31 | $4,834 |
| 2022-12-31 | $4,842 |
| 2022-09-30 | $4,603 |
| 2022-06-30 | $4,850 |
| 2022-03-31 | $5,105 |
| 2021-12-31 | $5,152 |
| 2021-09-30 | $5,182 |
| 2021-06-30 | $5,511 |
| 2021-03-31 | $5,558 |
| 2020-12-31 | $5,655 |
| 2020-09-30 | $5,820 |
| 2020-06-30 | $5,911 |
| 2020-03-31 | $5,787 |
| 2019-12-31 | $5,804 |
| 2019-09-30 | $5,759 |
| 2019-06-30 | $5,726 |
| 2019-03-31 | $5,701 |
| 2018-12-31 | $5,668 |
| 2018-09-30 | $5,660 |
| 2018-06-30 | $5,897 |
| 2018-03-31 | $6,206 |
| 2017-12-31 | $6,171 |
| 2017-09-30 | $6,042 |
| 2017-06-30 | $6,081 |
| 2017-03-31 | $6,067 |
| 2016-12-31 | $5,958 |
| 2016-09-30 | $7,483 |
| 2016-06-30 | $9,048 |
| 2016-03-31 | $9,725 |
| 2015-12-31 | $10,107 |
| 2015-09-30 | $10,732 |
| 2015-06-30 | $10,663 |
| 2015-03-31 | $9,586 |
| 2014-12-31 | $9,715 |
| 2014-09-30 | $8,717 |
| 2014-06-30 | $8,694 |
| 2014-03-31 | $8,559 |
| 2013-12-31 | $8,501 |
| 2013-09-30 | $2,470 |
| 2013-06-30 | $2,333 |
| 2013-03-31 | $2,225 |
| 2012-12-31 | $2,108 |
| 2012-09-30 | $1,965 |
| 2012-06-30 | $1,853 |
| 2012-03-31 | $1,773 |
| 2011-12-31 | $1,631 |
| 2011-09-30 | $1,544 |
| 2011-06-30 | $1,531 |
| 2011-03-31 | $1,425 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.052B | $4.373B |
| Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $209.934B | 24.19 |
| EssilorLuxottica (ESLOY) | France | $146.214B | 0.00 |
| Stryker (SYK) | United States | $138.797B | 27.56 |
| Boston Scientific (BSX) | United States | $135.955B | 31.09 |
| Medtronic (MDT) | Ireland | $128.573B | 17.81 |
| Medline (MDLN) | United States | $56.884B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.666B | 0.00 |
| Agilent Technologies (A) | United States | $39.625B | 25.05 |
| ResMed (RMD) | United States | $37.840B | 26.19 |
| GE HealthCare Technologies (GEHC) | United States | $36.943B | 17.67 |
| Koninklijke Philips (PHG) | Netherlands | $28.127B | 18.37 |
| Terumo (TRUMY) | Japan | $20.195B | 22.73 |
| Insulet (PODD) | United States | $20.046B | 62.22 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.153B | 10.70 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.928B | 0.00 |
| Baxter (BAX) | United States | $10.132B | 8.18 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.404B | 30.22 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.406B | 13.42 |
| Envista Holdings (NVST) | United States | $4.056B | 23.27 |
| BillionToOne (BLLN) | United States | $3.850B | 0.00 |
| ICU Medical (ICUI) | United States | $3.830B | 24.32 |
| Haemonetics (HAE) | United States | $3.282B | 14.61 |
| Prestige Consumer Healthcare (PBH) | United States | $3.222B | 14.69 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| Neogen (NEOG) | United States | $2.147B | 47.00 |
| QuidelOrtho (QDEL) | United States | $1.999B | 12.85 |
| LeMaitre Vascular (LMAT) | United States | $1.973B | 39.72 |
| AtriCure (ATRC) | United States | $1.952B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.700B | 16.98 |
| Curaleaf Holdings (CURLF) | Canada | $1.649B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.608B | 70.46 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.431B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.425B | 20.63 |
| Kestra Medical Technologies (KMTS) | United States | $1.377B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.230B | 365.00 |
| Capricor Therapeutics (CAPR) | United States | $1.111B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.010B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.979B | 0.00 |
| InMode (INMD) | Israel | $0.893B | 10.09 |
| Omeros (OMER) | United States | $0.856B | 0.00 |
| Valneva SE (VALN) | France | $0.854B | 0.00 |
| CeriBell (CBLL) | United States | $0.822B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.593B | 16.08 |
| Verano Holdings (VRNO) | United States | $0.494B | 0.00 |
| Cerus (CERS) | United States | $0.486B | 0.00 |
| Brainsway (BWAY) | Israel | $0.454B | 77.27 |
| Cresco Labs (CRLBF) | United States | $0.422B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.420B | 0.00 |
| SNDL (SNDL) | Canada | $0.415B | 0.00 |
| Quanterix (QTRX) | United States | $0.329B | 0.00 |
| Evolus (EOLS) | United States | $0.318B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.285B | 22.70 |
| TriSalus Life Sciences (TLSI) | United States | $0.276B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.240B | 141.33 |
| Sanuwave Health (SNWV) | United States | $0.236B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.234B | 0.00 |
| High Tide (HITI) | Canada | $0.228B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Organigram Global (OGI) | Canada | $0.216B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.203B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.201B | 17.73 |
| OraSure Technologies (OSUR) | United States | $0.199B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Accendra Health (ACH) | United States | $0.166B | 1.66 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.156B | 0.00 |
| Apyx Medical (APYX) | United States | $0.153B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.137B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.84 |
| Jushi Holdings (JUSHF) | United States | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.110B | 0.00 |
| Exagen (XGN) | United States | $0.107B | 0.00 |
| Biote (BTMD) | United States | $0.105B | 4.58 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| ImmuCell (ICCC) | United States | $0.062B | 26.15 |
| Rockwell Medical (RMTI) | United States | $0.048B | 0.00 |
| Nephros (NEPH) | United States | $0.048B | 35.08 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Veru (VERU) | United States | $0.042B | 0.00 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.19 |
| Bonk (BNKK) | United States | $0.025B | 0.00 |
| Jin Medical (ZJYL) | China | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |